A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration
26/06/2019
INVESTIGADOR:
Dr. Álvaro Fernández-Vega Sanz
RECLUTANDO
A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration.
PATOLOGÍA: DMAE
TRATAMIENTO: Conbercept
CÓDIGO DE ESTUDIO: PANDA
PROMOTOR: Chengdu Kanghong Biotechnology Co, Ltd.
(Klonopin)
0